B. thuringiensis serovar kurstaki cry1Aa neutralizing antibodies
During the past decade, thousands of NeutraABs have been isolated and expressed. These antibodies are now guiding the design of novel vaccine candidate for virus infection or used for biological therapeutics in any class of large molecule drugs. Creative Biolabs' unparalleled skill in mammalian cell (293F or CHO) transient transfection and transient transfection platform enables us to provide a wide range of NeutraABs with high-quality in short time.